TETMedical continues development of NSE-FAST, the first in-vitro diagnostic blood test for brain injury from stroke, with clinical studies underway and FDA pivotal study planned for Summer 2026. Read more on TETMedical →
Biotia closes a $3 million seed round led by Burnt Island Ventures to scale rapid PFAS testing and expand its environmental diagnostics platform.
Launchpoint and Reign Maker Group form a strategic venture to help enterprise brands scale creator campaigns with AI-powered infrastructure.
